K Koss

Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies

K Koss, Jack Satsangi, GC Fanning et al. · Genes and Immunity · 2000 · 198 citations

Life Sciences, Genetics, Immunology +17

The outcome of surgery in fulminant <i>Clostridium difficile</i> colitis

K Koss, M. A. Clark, D. S. A. Sanders et al. · Colorectal Disease · 2005 · 186 citations

Medicine, Infectious Diseases, Surgery +14

Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention

K Koss, D G Maxton, Janusz Jankowski · Colorectal Disease · 2007 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17

Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3′ mismatches in forward and reverse primers

K Koss, GC Fanning, KI Welsh et al. · Genes and Immunity · 2000 · 44 citations

Life Sciences, Genetics, Molecular Genetics +7

The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia–dysplasia–adenocarcinoma sequence in Barrett’s oesophagus

K Koss, Rebecca Harrison, J.S. Gregory et al. · Journal of Clinical Pathology · 2004 · 31 citations · Full text

Medicine, Oncology, Pathology +17